...from CFO to CEO. Philip Vickers joined Faze Medicines Inc. as CEO. He was president and CEO at Northern Biologics Inc. Launched...

...company Mosaic Biomedicals S.L., which merged with Northern Biologics Inc....

...an important but sparsely populated area of biology. The May 14 acquisition of Versant Ventures-built Northern Biologics Inc....
...into a five-year initiative to build its immuno-oncology pipeline. Boehringer Ingelheim GmbH’s takeout of the Northern Biologics...
...year of preclinical development. Versant’s Canadian success Northern Biologics’ CEO Vickers told BioCentury that Boehringer attracted Northern Biologics...

...membership. Oncology company Rgenix Inc. hired Robert Wasserman as CMO. Previously, he was CMO of Northern Biologics Inc....

...former global head of R&D at Shire from 2013-17 and now CEO of cancer company Northern Biologics Inc....
...said Curran. Senior Writer Allison Johnson contributed reporting for this story. Companies and Institutions Mentioned Northern Biologics Inc....

...combination also reduced tumor growth in a patient-derived xenograft (PDX) mouse model of the disease. Northern Biologics Inc....

...to respond to checkpoints,” said Joanne Hulme, VP and head of research at cancer company Northern Biologics Inc....
...pathways, and the contribution of each pathway may vary across different tumor types,” said English. Northern Biologics...
...Inc. (NYSE:MRK), Kenilworth, N.J. Merck KGaA (Xetra:MRK), Darmstadt, Germany Molecular Partners AG (SIX:MOLN), Schlieren, Switzerland Northern Biologics Inc....

...Hassan will become COO. Darlene Deptula-Hicks will succeed Hassan as CFO. She was CFO of Northern Biologics Inc....

...Studies pinpoints new mechanistic details about how LIF promotes pancreatic cancer, providing preclinical support for Northern Biologics'...
...adenocarcinoma (PDAC) progression and chemoresistance. Hunter is professor of molecular and cell biology at Salk. Northern Biologics Inc....
...its clinical trial. According to BioCentury's BCIQ database, Northern Biologics is the only company targeting LIF. Northern Biologics...

...of cancer immunotherapy development at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Immuno-oncology company Northern Biologics Inc....